DK0398283T3 - Stimulatoriske aminosyreantagonister - Google Patents

Stimulatoriske aminosyreantagonister

Info

Publication number
DK0398283T3
DK0398283T3 DK90109226.2T DK90109226T DK0398283T3 DK 0398283 T3 DK0398283 T3 DK 0398283T3 DK 90109226 T DK90109226 T DK 90109226T DK 0398283 T3 DK0398283 T3 DK 0398283T3
Authority
DK
Denmark
Prior art keywords
amino acid
acid antagonists
stimulatory amino
stimulatory
antagonists
Prior art date
Application number
DK90109226.2T
Other languages
Danish (da)
English (en)
Inventor
Boyd L Harrison
Bruce M Baron
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Application granted granted Critical
Publication of DK0398283T3 publication Critical patent/DK0398283T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK90109226.2T 1989-05-16 1990-05-16 Stimulatoriske aminosyreantagonister DK0398283T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US35242389A 1989-05-16 1989-05-16

Publications (1)

Publication Number Publication Date
DK0398283T3 true DK0398283T3 (da) 1994-11-28

Family

ID=23385074

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90109226.2T DK0398283T3 (da) 1989-05-16 1990-05-16 Stimulatoriske aminosyreantagonister

Country Status (19)

Country Link
EP (1) EP0398283B1 (fi)
JP (1) JP3014001B2 (fi)
KR (1) KR0169107B1 (fi)
CN (1) CN1027369C (fi)
AT (1) ATE113597T1 (fi)
AU (1) AU626418B2 (fi)
DE (1) DE69013750T2 (fi)
DK (1) DK0398283T3 (fi)
ES (1) ES2066035T3 (fi)
FI (1) FI95795C (fi)
GR (1) GR3014893T3 (fi)
HU (1) HU214322B (fi)
IE (1) IE64671B1 (fi)
IL (1) IL94377A (fi)
NO (1) NO177141C (fi)
NZ (1) NZ233641A (fi)
PT (1) PT94042B (fi)
TW (1) TW207950B (fi)
ZA (1) ZA903588B (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028707A (en) * 1989-11-20 1991-07-02 Board Of Regents, University Of Texas 4-hydroxyquinaldic acid derivatives
DK101290D0 (da) * 1990-04-24 1990-04-24 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5606063A (en) * 1991-02-27 1997-02-25 Merrell Pharmaceuticals Inc. NMDA antagonists
DE69210229T2 (de) * 1991-02-27 1996-11-14 Merrell Pharmaceuticals Inc., Cincinnati, Ohio Dihydrochinolin NMDA Antagonisten
GB9200781D0 (en) * 1992-01-15 1992-03-11 Merck Sharp & Dohme Therapeutic agents
US5464843A (en) * 1992-06-23 1995-11-07 G.D. Searle & Co. Imidazo[1,2-a]pyridinyldiacid compounds for cognitive enhancement and for treatment of cognitive disorders and neutrotoxic injury
FR2722786B1 (fr) * 1994-07-20 1996-08-23 Rhone Poulenc Rorer Sa Derives de 4-hydroxy-3-phenyl-indeno(1,2-b)pyridine-2(1h)- one, leur preparation et les medicaments les contenant
DE4444815A1 (de) * 1994-12-15 1996-06-20 Merck Patent Gmbh Thienopyridone
WO1997037999A1 (en) * 1996-04-04 1997-10-16 University Of Nebraska Board Of Regents Synthetic triple helix-forming compounds
RU2239631C2 (ru) * 1999-12-28 2004-11-10 Эйсай Ко., Лтд. Гетероциклические соединения, содержащие сульфонамидные группы, промежуточное соединение и антиангиогенный агент на их основе
WO2002072585A2 (de) * 2001-03-14 2002-09-19 Grünenthal GmbH Substituierte pyrazolo- und thiazolopyrimidine als analgetika
FR2864535B1 (fr) * 2003-12-24 2006-12-22 Merck Sante Sas Derives acides de quinoline et leurs applications en therapeutique
GB0420719D0 (en) * 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
EA017756B1 (ru) 2008-04-11 2013-02-28 Мерк Патент Гмбх Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк)
DE102008019838A1 (de) * 2008-04-19 2009-12-10 Boehringer Ingelheim International Gmbh Neue Arylsulfonylglycin-Derivate, deren Herstellung und deren Verwendung als Arzneimittel
WO2017121308A1 (en) * 2016-01-11 2017-07-20 Chongqing Fochon Pharmaceutical Co., Ltd. Fused pyridine compounds, compositions and methods of use
WO2018202039A1 (zh) * 2017-05-03 2018-11-08 成都海创药业有限公司 杂环化合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2563831B1 (fr) * 1984-05-04 1986-11-21 Sanofi Sa Nouveaux derives de thienopyridinone, leur procede de preparation et compositions pharmaceutiques les contenant
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
GB8804448D0 (en) * 1988-02-25 1988-03-23 Smithkline Beckman Intercredit Compounds
EP0403885A1 (de) * 1989-06-20 1990-12-27 Bayer Ag Verwendung von 3-Hydroxybenzothiophenen zur Bekämpfung von Endoparasiten, neue 3-Hydroxybenzothiophene und Verfahren zu ihrer Herstellung
EP0446604A3 (en) * 1990-03-16 1992-02-19 American Cyanamid Company Pyridine and related aza heterocycle derivatives as cardiovascular agents

Also Published As

Publication number Publication date
FI902416A0 (fi) 1990-05-15
IE901750L (en) 1990-11-16
GR3014893T3 (en) 1995-05-31
NO902179D0 (no) 1990-05-15
TW207950B (fi) 1993-06-21
JPH0311067A (ja) 1991-01-18
FI95795C (fi) 1996-03-25
AU626418B2 (en) 1992-07-30
ATE113597T1 (de) 1994-11-15
CN1027369C (zh) 1995-01-11
HUT54657A (en) 1991-03-28
CN1047292A (zh) 1990-11-28
IL94377A (en) 1997-01-10
IL94377A0 (en) 1991-03-10
AU5491490A (en) 1990-11-22
KR900018112A (ko) 1990-12-20
NO177141C (no) 1995-07-26
HU903031D0 (en) 1990-09-28
NZ233641A (en) 1992-07-28
DE69013750T2 (de) 1995-05-24
KR0169107B1 (ko) 1999-01-15
ZA903588B (en) 1991-02-27
PT94042A (pt) 1991-01-08
JP3014001B2 (ja) 2000-02-28
EP0398283B1 (en) 1994-11-02
NO177141B (no) 1995-04-18
HU214322B (hu) 1998-03-02
ES2066035T3 (es) 1995-03-01
DE69013750D1 (de) 1994-12-08
IE64671B1 (en) 1995-08-23
NO902179L (no) 1990-11-19
EP0398283A1 (en) 1990-11-22
PT94042B (pt) 1997-05-28
FI95795B (fi) 1995-12-15

Similar Documents

Publication Publication Date Title
DK0398283T3 (da) Stimulatoriske aminosyreantagonister
DE69033308D1 (de) Decahydro-isochinolin-derivate
MX9203338A (es) Nuevos derivados del oxico a_nor-esteroide-3-carboxilico.
DE69021618D1 (de) Antagonisten von exzitatorischen Aminosäuren.
DK565987A (da) Substituerede aminosyrer
DE69118539D1 (de) Exzitatorische Aminosäureantagonisten
DK0624574T3 (da) Hidtil ukendte prostaglandinanaloger
ATE87918T1 (de) Tetrazolverbindungen als antagonisten der excitatorischen aminosaeurerezeptoren.
ATE79637T1 (de) Substituierte alkylamide von teicoplaninverbindungen.
PT86233A (fr) Procede de preparation d:une variant de l:hirudine
BR9206404A (pt) Heteroaril-polimiaminas sintéticas como antagonistas de neurotransmissores aminoácidos excitadores
DE69230224D1 (de) Potenzierung von nmda-antagonisten
PT90504A (pt) Processo para a preparacao de alcoois peptidicos com actividade anticoagulante
IT8819603A0 (it) Analoghi della ammino prostaglandina 7 ossabicicloeptansostituiti.
ES2083478T3 (es) Antagonistas de nmda heterociclicos.
DE69011702D1 (de) Derivate von Aminocarboxylsäure.
DK196489D0 (da) Carbamatderivater samt en fremgangsmaade til fremstilling heraf
ATE66459T1 (de) Herstellungsverfahren von trifluormethylverbindungen.